{"slideshow_credits": null, "snippet": "The deal, to be announced Monday, would create a huge new pharmaceutical giant and could potentially help Pfizer lower its American tax rate.", "abstract": "Drug company Pfizer closes deal to take over Allergan, maker of Botox, in merger worth more than $150 billion that is one of largest in drug industry history; Dublin-based Allergan, although smaller, is technically buyer in deal, allowing Pfizer to shed its American corporate citizenship and lower its tax bill; deal is among corporate inversions Obama administration is trying to limit and may figure in 2016 presidential election.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"lastname": "de la MERCED", "rank": 1, "firstname": "Michael", "role": "reported", "organization": "", "middlename": "J."}], "original": "By MICHAEL J. de la MERCED"}, "web_url": "http://www.nytimes.com/2015/11/23/business/dealbook/pfizer-and-allergan-reach-150-billion-merger-deal.html", "lead_paragraph": "The deal, to be announced Monday, would create a huge new pharmaceutical giant and could potentially help Pfizer lower its American tax rate.", "headline": {"main": "Pfizer and Allergan Reach $150 Billion Merger Deal", "print_headline": "Pfizer Reaches Takeover Deal With Allergan "}, "_id": "56521a0b38f0d83c3238d9c9", "word_count": "1113", "multimedia": [{"height": 126, "url": "images/2015/11/23/business/23db-drug-web2/23db-drug-web2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/11/23/business/23db-drug-web2/23db-drug-web2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2015/11/23/business/23db-drug-web2/23db-drug-web2-articleLarge.jpg", "legacy": {"xlarge": "images/2015/11/23/business/23db-drug-web2/23db-drug-web2-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/11/23/business/23db-drug-web2/23db-drug-web2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/11/23/business/23db-drug-web2/23db-drug-web2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-11-23T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Allergan Inc", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Pfizer Inc", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Tax Shelters", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Botox (Drug)", "is_major": "N", "rank": "6"}, {"name": "subject", "value": "Corporate Taxes", "is_major": "N", "rank": "7"}, {"name": "subject", "value": "Relocation of Business", "is_major": "N", "rank": "8"}, {"name": "organizations", "value": "Treasury Department", "is_major": "N", "rank": "9"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}